利托君用于先兆早产合并前置胎盘对产妇出血及新生儿结局的临床观察

龙源期刊网 http://www.qikan.com.cn

利托君用于先兆早产合并前置胎盘对产妇出血及新生儿结局的临床观察

作者：聂爱宏

来源：《上海医药》2017年第19期

摘 要 目的：探讨利托君用于先兆早产合并前置胎盘对产妇出血及新生儿结局的影响。方法：选取68例先兆早产合并前置胎盘患者随机分为对照组（予硫酸镁注射液）和研究组（予盐酸利托君注射液）各34例。比较两组患者的保胎效果、阴道出血量、新生儿结局及不良反应发生情况。结果：研究组患者的保胎成功率和延长孕周时间明显高于对照组（94.12% vs 76.47%）、[（17.68±14.72）d vs （11.19±10.12）d]，而阴道出血量低于对照组

[（224.73±6.54）ml vs （274.38±7.52）ml] （P0.05）。结论：利托君用于先兆早产合并前置胎盘的治疗，可延长孕周时间，提高保胎成功率，改善新生儿结局，安全有效，值得应用于临床。

关键词 利托君 前置胎盘 先兆早产 新生儿结局

中图分类号：R984； R714.21 文献标识码：B 文章编号：1006-1533（2017）19-0020-03 Clinical observation of ritodrine on colporrhagia and neonatal outcomes in patients with threatened premature labor and placenta previa* NIE Aihong

（Department of Obstetrics， the People’s Hospital of Fengcheng City， Fengcheng 331100， China）

ABSTRACT Objective： To discuss the clinical observation of ritodrine on colporrhagia and neonatal outcomes in patients with threatened premature labor and placenta previa. Methods： Sixty-eight patients with threatened premature labor and placenta previa were randomly selected and divided into a control group （giving magnesium sulfate injection） and a research group （giving ritodrine hydrochloride injection） with 34 patients each. The effect of fetal protection， vaginal bleeding volume， neonatal outcomes and adverse reactions were compared between the two groups. Results： The success rate of the fetal protection was higher （94.12% vs 76.4%） and the time for the delayed pregnancy was longer [（17.68±14.72） d vs （11.19±10.12） d] while the vaginal bleeding volume was less [（224.73±6.54） ml vs （274.38±7.52） ml] in the research group than in the control group（P0.05）. Conclusion： Ritodrine for the treatment of patients with threatened premature labor and placenta previa can extend gestational age， increase the success rate of fetal protection and improve the neonatal outcomes， which is safe and effective and worthy of clinical use.

本文来源：https://www.bwwdw.com/article/7yyt.html